BioCryst Pharmaceuticals(BCRX)
DURHAM, NCPharmaceutical
Focus: BioCryst is a specialty pharmaceutical company focused on small-molecule therapies, primarily concentrated in rare disease and neurology. The company is public (NASDAQ: BCRX) and headquartered in Durham, NC, with a single commercial product generating all revenue.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
7
Should You Work at BioCryst Pharmaceuticals?
AI assessmentBioCryst is a focused rare-disease player with strong commercial momentum in a single asset, but revenue concentration and recent restructuring signal near-term instability despite a credible pipeline.
Why Work Here
- Focused commercial execution: ORLADEYO generated $52M in Part D spending and drove FY2025 revenue to $331M (+22% YoY), demonstrating strong rare-disease market penetration.
Data completeness
7/9 — Strong
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
1 imminent
RAPIVAB
Hiring
Stable
Revenue
$331M
FY2025
Key Products
$52M Part DGrowing
Peak
Help build intelligence for BioCryst Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.